Quantcast

Latest Drug-eluting stent Stories

2014-09-15 12:26:57

- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device used in the heart that functions like a stent but dissolves over time ABBOTT PARK, Ill., Sept. 15, 2014 /PRNewswire/ -- Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent. Absorb is the...

2014-09-14 12:20:52

- Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device, used in the heart, that functions like a stent but dissolves over time WASHINGTON, Sept. 14, 2014 /PRNewswire/ -- Abbott announced today positive one-year clinical results from ABSORB II, the world's first prospective, randomized, controlled trial comparing the safety and effectiveness of the dissolving Absorb heart device to Abbott's market-leading metallic XIENCE family of DES. The trial,...

2014-08-06 08:32:12

SINGAPORE, Aug. 6, 2014 /PRNewswire/ -- Biosensors International Group, Ltd. ("Biosensors" or the "Company", Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its first fiscal quarter ended 30 June 2014 ("Q1 FY15"). Quarter Highlights and Recent Developments: -- Total revenue was US$80.2 million, representing a 5% growth from the quarter ended 30 June 2013 ("Q1 FY14")....

2014-08-04 12:26:09

LONDON, Aug. 4, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Peripheral Vascular Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018 http://www.reportbuyer.com/pharma_healthcare/medical_devices/peripheral_vascular_devices_emerging_markets_brazil_russia_india_china_south_africa_south_korea_2009_2015.html Global Market Watch: BRICSS Peripheral Vascular Devices sector forecasts to reach at US$732 million by 2016....

2014-07-22 12:28:16

Although Procedure Volume Expansion Is Faster Than Other Developed Markets, This Will Be Largely Offset By Price Declines, According to Findings from Decision Resources Group BURLINGTON, Mass., July 22, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for interventional cardiology (IC) devices in Canada will remain relatively stagnant at a value of around $80 million through 2022. This is despite the fact that percutaneous coronary intervention (PCI) volumes are growing...

2014-07-21 16:26:15

Advanced Bare-Metal Stent Provides Additional Treatment Option for Interventional Cardiologists and Patients MARLBOROUGH, Mass., July 21, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received FDA approval for the REBEL(TM) Platinum Chromium Coronary Stent System, the company's latest generation bare-metal stent for the treatment of coronary artery disease (CAD). Bare-metal stents continue to play an important role in the treatment of CAD and represent a...

2014-07-21 04:21:50

DUBLIN, July 22, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/m3xbsf/global_coronary) has announced the addition of the "Global Coronary Stents Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 A coronary stent is a tiny mesh-like tube made up of thin wires of stainless steel, cobalt-based alloy with mechanism of self-expansion. Coronary stents are used to prevent artery blockages that may occur in...

2014-07-15 08:28:52

Strengthens Leadership Team with Addition of Experienced Medical Device Executive BOSTON, July 15, 2014 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, today announced the appointment of James Barry, Ph.D. as Chief Operating Officer. Barry, who has more than two decades of experience in the medical device industry, will be based in the Company's Boston headquarters. Dr. Barry will focus on three critical...

2014-07-09 12:30:56

Efforts to Reduce Overstenting and Price Competition Will Somewhat Restrict Market Expansion, According to Findings from Decision Resources Group BURLINGTON, Mass., July 9, 2014 /PRNewswire/ -- Decision Resources Group finds that the market for interventional cardiology (IC) devices still holds considerable potential for growth in the Asia Pacific, despite stagnating in recent years in the United States and Europe. This is particularly true in China and India, where expanding economies are...

2014-07-09 08:28:18

-- Newly Issued US Patent Covers Medical Device Coating Process and Compositions -- DURHAM, N.C., July 9, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued a patent related to Micell's technology for enhancing the performance of medical devices with precise drug-delivery coatings. These technologies currently are used in producing the company's drug-eluting stent system, MiStent SES(®). The...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.